ESTELA NATIVIDAD
PAZ ARTAL
Profesora asociada de Ciencias de la Salud
ANTONIO
LALUEZA BLANCO
Profesor asociado de Ciencias de la Salud
Publicaciones en las que colabora con ANTONIO LALUEZA BLANCO (13)
2022
-
An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution
Biomedicines, Vol. 10, Núm. 2
-
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
International Journal of Infectious Diseases, Vol. 117, pp. 56-64
-
Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution
International Journal of Molecular Sciences, Vol. 23, Núm. 12
-
Shorter telomere length is associated with COVID-19 hospitalization and with persistence of radiographic lung abnormalities
Immunity and Ageing, Vol. 19, Núm. 1
2021
-
A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID
Biomedicines, Vol. 9, Núm. 11
-
Alterations in circulating monocytes predict covid-19 severity and include chromatin modifications still detectable six months after recovery
Biomedicines, Vol. 9, Núm. 9
-
Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019
ACR Open Rheumatology, Vol. 3, Núm. 4, pp. 267-276
-
Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome
Frontiers in Immunology, Vol. 12
-
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study
International Journal of Infectious Diseases, Vol. 105, pp. 487-494
-
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study
International Journal of Infectious Diseases, Vol. 105, pp. 319-325
-
Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
PLoS Pathogens, Vol. 17, Núm. 12
-
SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy
Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 6, pp. 1258-1262
-
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression
Frontiers in Cellular and Infection Microbiology, Vol. 11